The antifungal effect of silver nanoparticles on Trichosporon asahii

Journal of Microbiology, Immunology and Infection

Volumn 49, Issue 2, 2016, Pages 182-188

  Xia, Zhi Kuan ^a,b   Ma, Qiu Hua ^a   Li, Shu Yi ^a   Zhang, De Quan ^a   Cong, Lin ^a   Tian, Yan Li ^a   Yang, Rong Ya ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antifungal activity; Electron microscopy; Minimum inhibitory concentration; Silver nanoparticles; Trichosporon asahii

Indexed keywords

ANTIINFECTIVE AGENT; CULTURE MEDIUM; NANOPARTICLE; SILVER;

CELL MEMBRANE; CELL WALL; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MICROBIAL SENSITIVITY TEST; PERMEABILITY; PHYSIOLOGY; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; TRICHOSPORON; ULTRASTRUCTURE;

ANTI-INFECTIVE AGENTS; CELL MEMBRANE; CELL WALL; CULTURE MEDIA; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PERMEABILITY; SILVER; TRICHOSPORON;

EID: 84901087875     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2014.04.013     Document Type: Article

References (37)

1. Saifuddin N., Wong C.W., Nur Yashumira A.A. Rapid biosynthesis of silver nanoparticles using culture supernatant of bacteria with microwave irradiation. E J Chem 2009, 6:61-70.
2. Morones J.R., Elechiguerra J.L., Camacho A., Holt K., Kouri J.B., Ramírez J.T., et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 6:2346-2353.
3. Dahl J.A., Maddux B.L., Hutchison J.E. Toward greener nanosynthesis. Chem Rev 2007, 107:2228-2269.
4. Ito D., Jespersen M.L., Hutchison J.E. Selective growth of vertical ZnO nanowire arrays using chemically anchored gold nanoparticles. ACS Nano 2008, 2:2001-2006.
5. Rai M., Yadav A., Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 2009, 27:76-83.
6. Sundaramoorthi C., Devarasu S., Vengadesh Prabhu K. Antimicrobial and wound healing activity of silver nanoparticles synthesized from Streptomyces aureofaciens. Int J Pharm Res Dev 2011, 2:69-75.
7. Ravichandran R. Nanotechnology-based drug delivery systems. Nanobiotechnology 2009, 5:17-33.
8. Seth D., Roy Choudhury S., Pradhan S., Gupta S., Palit D., Das S., et al. Nature-inspired novel drug design paradigm using nanosilver: efficacy on multi-drug-resistant clinical isolates of tuberculosis. Curr Microbiol 2010, 62:715-726.
9. Kim K.J., Sung W.S., Suh B.K., Moon S.K., Choi J.S., Kim J.G., et al. Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometals 2009, 22:235-242.
10. Lara H.H., Ayala-Nuñez N.V., Ixtepan-Turrent L., Rodriguez-Padilla C. Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotechnol 2010, 8:1-8.
11. Lu L., Sun R.W., Chen R., Hui C.K., Ho C.M., Luk J.M., et al. Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther 2008, 13:253-262.
12. Sun L., Singh A.K., Vig K., Pillai S.R., Singh S.R. Silver nanoparticles inhibit replication of respiratory syncytial virus. J Biomed Nanotechnol 2008, 4:149-158.
13. Li C., Wang X., Chen F., Zhang C., Zhi X., Wang K., et al. The antifungal activity of graphene oxide-silver nanocomposites. Biomaterials 2013, 34:3882-3890.
14. Monteiro D.R., Silva S., Negri M., Gorup L.F., de Camargo E.R., Oliveira R., et al. Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms. Mycoses 2013, 56:672-680.
15. Wijnhoven S.W.P., Peijnenburg W.J.G.M., Herberts C.A., Hagens W.I., Oomen A.G., Heugens E.H.W., et al. Nano-silver-a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009, 3:109-138.
16. Kumar S., Bandyopadhyay M., Mondal S., Pal N. A rare case of nosocomial urinary tract infection due to Trichosporon asahii. J Glob Infect Dis 2011, 3:309-310.
17. Bayramoglu G., Sonmez M., Tosun I., Aydin K., Aydin F. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. Infection 2008, 36:68-70.
18. Matsue K., Uryu H., Koseki M., Asada N., Takeuchi M. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin Infect Dis 2006, 15:753-757.
19. Biasoli M.S., Carlson D., Chiganer G.J., Parodi R., Greca A., Tosello M.E., et al. Systemic infection caused by Trichosporon asahii in a patient with liver transplant. Med Mycol 2008, 46:719-723.
20. Gross J.W., Kan V.L. Trichosporon asahii infection in an advanced AIDS patient and literature review. AIDS 2008, 22:793-795.
21. Kim S.W., Kim K.S., Lamsal K., Kim Y.J., Kim S.B., Jung M., et al. An in vitro study of the antifungal effect of silver nanoparticles on oak wilt pathogen Raffaelea sp. J Microbiol Biotechnol 2009, 19:760-764.
22. Stoimenov P.K., Klinger R.L., Marchin G.L., Klabunde K.J. Metal oxide nanoparticles as bactericidal agents. Langmuir 2002, 18:6679-6686.
23. National Committee for Clinical Laboratory Standards Reference method for broth dilution antifungal susceptibility testing of yeasts 2002, Approved standard M27-A2, Clinical and Laboratory Standards Institute, Wayne, PA.
24. Quadros M.E., Marr L.C. Silver nanoparticles and total aerosols emitted by nanotechnology-related consumer spray products. Environ Sci Technol 2011, 45:10713-10719.
25. Faunce T., Watal A. Nanosilver and global public health: international regulatory issues. Nanomedicine 2010, 5:617-632.
26. Kalaiselvi A., Gantz S., Ramalingam C. Effects of silver nanoparticles on storage stability of raw milk. Int J Pharm Pharm Sci 2013, 5:274-277.
27. Feng Q.L., Wu J., Chen G.Q., Cui F.Z., Kim T.N., Kim J.O. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 2002, 52:662-668.
28. Kim J.S., Kuk E., Yu K.N., Kim J.H., Park S.J., Lee H.J., et al. Antimicrobial effects of silver nanoparticles. Nanomedicine 2007, 3:95-101.
29. +) in Vibrio cholerae. Antimicrobial Agents Chemother 2002, 46:2668-2670.
30. Raffi M., Hussain F., Bhatti T.M., Akhter J.I., Hameed A., Hasan M.M. Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224. J Mater Sci Technol 2008, 24:192-196.
31. Kim J., Lee J., Kwon S., Jeong S. Preparation of biodegradable polymer/silver nanoparticles composite and its antibacterial efficacy. J Nanosci Nanotechnol 2009, 9:1098-1102.
32. Du H., Lo T.M., Sitompul J., Chang M.W. Systems-level analysis of Escherichia coli response to silver nanoparticles: the roles of anaerobic respiration in microbial resistance. Biochem Biophys Res Commun 2012, 424:657-662.
33. Carlson C., Hussain S.M., Schrand A.M., Braydich-Stolle L.K., Hess K.L., Jones R.L., et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B 2008, 112:13608-13619.
34. Foldbjerg R., Dang D.A., Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol 2011, 85:743-750.
35. AshaRani P.V., Low Kah Mun G., Hande M.P., Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3:279-290.
36. Borase H.P., Patil C.D., Sauter I.P., Rott M.B., Patil S.V. Amoebicidal activity of phytosynthesized silver nanoparticles and their in vitro cytotoxicity to human cells. FEMS Microbiol Lett 2013, 345:127-131.
37. Pauksch L., Hartmann S., Rohnke M., Szalay G., Alt V., Schnettler R., et al. Biocompatibility of silver nanoparticles and silver ions in primary human mesenchymal stem cells and osteoblasts. Acta Biomater 2014, 10:439-449.